Synthesis 2008(24): 4007-4011  
DOI: 10.1055/s-0028-1083239
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Multicomponent Reactions as a Powerful Tool for Generic Drug Synthesis

Cédric Kalinski*, Hugues Lemoine, Jürgen Schmidt, Christoph Burdack, Jürgen Kolb, Michael Umkehrer, Günther Ross
Priaxon AG, Gmunder Str. 37-37a, 81739 München, Germany
Fax: +49(89)452130822; e-Mail: kalinski@priaxon.com;
Further Information

Publication History

Received 11 April 2008
Publication Date:
01 December 2008 (online)

Abstract

Multicomponent reactions (MCRs) are not only a powerful tool for drug discovery, they also represent an excellent methodology for synthesis rationalization. Here we wish to illustrate the potential of MCRs in the production of generic drugs by synthesizing, in racemic form, the antiplatelet agent clopidogrel and the non-steroidal antiandrogen bicalutamide, using Ugi, Petasis and Passerini reactions.

    References

  • 1a Dömling A. Ugi I. Angew. Chem. Int. Ed.  2000,  39:  3168 
  • 1b Dömling A. Chem. Rev.  2006,  106:  17 
  • 2 Hulme C. In Multicomponent Reactions   Zhu J. Bienayme H. Wiley-VCH; Weinheim: 2005. 
  • 3a Rossen K. Pye PJ. DiMichele LM. Volante RP. Reider PJ. Tetrahedron Lett.  1998,  39:  6823 
  • 3b Askin D. Eng KK. Rossen K. Purick RM. Wells KM. Volante RP. Reider PJ. Tetrahedron Lett.  1994,  35:  673 
  • 4 Endo A. Yanagisawa A. Abe M. Tohma S. Kan T. Fukuyama T. J. Am. Chem. Soc.  2002,  124:  6552 
  • 5a Gurbel PA. O’Connor CM. Cummings CC. Serebruany VL. Pharm. Res.  1999,  40:  107 
  • 5b Jacobson AK. Best Pract. Res. Clin. Haematol.  2004,  17:  55 
  • 6a Ugi I. Meyer R. Fetzer U. Steinbrückner C. Angew. Chem.  1959,  71:  386 
  • 6b Ugi I. Angew. Chem., Int. Ed. Engl.  1962,  1:  8 
  • 6c Dömling A. Ugi I. Angew. Chem.  2000,  112:  3300 
  • 7 Keating TA. Armstromg W. J. Am. Chem. Soc.  1996,  118:  2574 
  • 8 Petasis NA. Akritopoulou I. Tetrahedron Lett.  1993,  34:  583 
  • 9 Petasis NA. Zavialov IA. J. Am. Chem. Soc.  1997,  119:  445 
  • 10 Lindhorst T. Bock H. Ugi I. Tetrahedron  1999,  55:  7411 
  • 11a Eliel EL. Fisk MT. Prosser T. Org. Synth. Coll. Vol. IV   John Wiley & Sons; London: 1963.  p.169 
  • 11b Aubert D, Ferrand C, and Maffrand J.-P. inventors; French Patent  FR2530247. 
  • 11c Badorc A, and Frehel D. inventors; US Patent  4847265. 
  • 11d Tucker H. inventors; US Patent  4636505. 
  • 11e Soeroes B, Tuba Z, Galik G, Bor A, Demeter A, Trischler F, Horvath J, and Brlik J. inventors; US Patent  7199257. 
  • 12a Pirrung MC. Ghorai S. J. Am. Chem. Soc.  2006,  128:  11772 
  • 12b Kreye O. Westermann B. Wessjohann LA. Synlett  2007,  3188 
  • 12c Gilley CB. Buller MJ. Kobayashi Y. Org. Lett.  2007,  9:  3631 
  • 13a Masiello D. Cheng S. Bubley GJ. Lu ML. Balk SP. J. Biol. Chem.  2002,  29:  26321 
  • 13b Hodgson MC. Astapova I. Hollenberg AN. Balk SP. Cancer Res.  2007,  67:  8388 
  • 14a Passerini M. Gazz. Chim. Ital.  1921,  51:  126 
  • 14b Passerini M. Gazz. Chim. Ital.  1921,  51:  181 
  • 15a Schiess M. Seebach D. Helv. Chim. Acta  1983,  66:  1618 
  • 15b Seebach D. Adam G. Gees T. Schiess M. Weigand W. Chem. Ber.  1988,  121:  507 
  • 15c Seebach D. Beck AK. Schiess M. Widler L. Wonnacott A. Pure Appl. Chem.  1983,  55:  1807 
  • 16 Carofiglio T. Cozzi PG. Floriani C. Organometallics  1993,  12:  2726 
  • 17 Semple JE. Owens TD. Nguyen K. Levy OE. Org. Lett.  2000,  2:  2769 
  • 18 James KD. Ekwuribe NN. Tetrahedron  2002,  58:  5905 
  • 19 James KD. Ekwuribe NN. Synthesis  2002,  850 
  • 20 Obrecht R. Herrmann R. Ugi I. Synthesis  1985,  400